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Viral RNA was extracted from plasma samples collected from five individuals during the period of viremia
before seroconversion in primary infection with human immunodeficiency virus type 1 (HIV-1) and amplified
by polymerase chain reaction. Nucleotide sequence analysis of amplified DNA from the V3 and V4
hypervariable regions indicated that the initial virus population of each acutely infected individual was
completely homogeneous in sequence. No intrasample variability was found among the 44,090 nucleotides
sequenced in this region of env, contrasting with the high degree of variability normally found in seropositive
individuals. Paradoxically, substantial sequence variability was found in the normally highly conserved gag
gene (encoding p17) in most of the preseroconversion samples. The diversity of p17 sequences in samples that
were homogeneous in V3 and V4 can most readily be explained by the existence of strong selection for specific
env sequences either upon transmission or in the interval between exposure and seroconversion in the exposed
individual. Evidence that localizes the selected region upon transmission to V3 is provided by the similarity or
identity of V3 loop sequences in five individuals with epidemiologically unrelated HIV-1 infections, while
regions flanking the V3 loop and the V4 hypervariable region were highly divergent. The actual V3 sequences
were similar to those associated with macrophage tropism in primary isolates of HIV, irrespective of whether
infection was acquired by sexual contact or parenterally through transfusion of contaminated factor VIII.
Proviral DNA sequences in peripheral blood mononuclear cells remained homogeneous in the V3 and V4
regions (and variable in p179`9) for several months after seroconversion. The persistence of HIV sequences in
peripheral blood mononuclear cells identical to those found at primary infection in the absence of continued
virus expression provides an explanation for the previously observed differences in the composition of
circulating DNA and RNA populations in sequential samples from seropositive individuals.
Infection with human immunodeficiency virus type 1
(HIV-1) is characterized by a slow but inexorable course of
disease leading ultimately to AIDS. A striking feature of
HIV infection is the diversity and rapid turnover of sequence
variants within an infected individual (28, 32, 49, 58). In
particular, the region of the viral genome that encodes the
external membrane glycoprotein (gpl20) encoded by the
HIV env gene shows an extremely rapid rate of sequence
change, concentrated into five hypervariable domains (Vi to
V5) interspersed among less variable regions (Cl to C4). The
V3 and V2 hypervariable regions have been shown to be the
targets of neutralizing antibody elicited by natural infection
(17, 18, 21, 26, 31, 41), and it has been speculated that high
rates of sequence change in these regions may have adaptive
value in allowing immunological escape from the initially
effective antiviral immune response upon primary infection
and enable long-term persistence of HIV (29, 59, 63). Alter-
natively, the observed sequence turnover of distinct gp120
sequence variants in plasma (49, 58) may result from sam-
pling of variants that are adapted for infection of different
cell types in vivo, such as cells of the monocyte/macrophage
lineage. Supporting this latter hypothesis is the mapping of
several determinants of in vitro phenotype observed upon
culture of HIV, such as cell tropism, cytopathology, and
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ability to grow in transformed T-cell lines, to parts of the env
gene that include the V3 hypervariable region (5, 16, 20, 36,
46, 50, 55, 56) and the observation that the phenotype of
virus isolated from seropositive individuals switches from
non-syncytium inducing (NSI) to syncytium inducing (SI)
during disease progression (16, 44, 52).
The relationship between the heterogeneous virus popu-
lation in long-term-infected individuals with that actually
transmitted to a sexual or parenteral contact remains un-
clear. In particular, it is not known whether infection is
normally initiated by a single virus particle or whether there
is cotransmission of several variants to the contact. Given
the evidence for selection for specific variants in long-term-
infected individuals (19), it is clearly important to determine
whether similar processes operate in the newly infected
individual before seroconversion. It is known that sequences
of virus in plasma collected from individuals shortly after
infection are less variable than those found in the contact at
the time of transmission (30, 60). There is also some evi-
dence for selective transmission of NSI and macrophage-
tropic variants, although whether this results from specific
transmission of HIV variants with the NSI phenotype, or
whether there is elimination of cotransmitted SI variants at
the time of primary infection, remains unclear (40, 54).
The aim of this study was to analyze the initial virus
population in the acute viremic stage of primary infection
before seroconversion for antibody to HIV. We have carried
out nucleotide sequence analysis of amplified viral RNA
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from plasma and proviral DNA sequences from peripheral
blood mononuclear cells (PBMCs) of the V3 and V4 hyper-
variable regions and part of the gag gene from three individ-
uals infected by sexual contact and six hemophiliacs with
acute infection from transfusion of HIV-contaminated factor
VIII. This procedure has enabled an investigation of the
extent of variation in different regions of the viral genome,
the relationship between env and gag sequences of individ-
uals infected from a common source (27), and the nature of
the V3 and V4 sequences upon transmission. The results
presented here confirm that selection for particular HIV env
variants does occur upon primary infection and provide an
insight into the nature of the selection process operating
before seroconversion.
MATERIALS AND METHODS
Samples. Heparinized plasma samples collected around
the time of seroconversion in three hemophiliacs, p82, p74,
and p84, and three heterosexual contacts of HIV-positive
individuals, Scl, Sc2, and Sc3, were separated and stored on
the day of collection at -20°C. PBMC samples collected 3 to
25 weeks after seroconversion from p28, p77, p79, p84, and
Sc3 were prepared by separation of heparinized blood over
Ficoll (Nyegaard); cells at the interface were washed in
phosphate-buffered saline (PBS), resuspended in 50% fetal
calf serum-40% PBS-10% dimethyl sulfoxide, and stored in
aliquots in liquid nitrogen until required. Samples were also
available from p82 5 years after infection and from s44, a
long-term-infected male homosexual with AIDS.
HIV serology. Pre- and postseroconversion samples were
tested for anti-HIV and p24 antigen by Abbott second-
generation enzyme immunoassay and Coulter or Dupont p24
antigen assay, respectively, carried out in accordance with
the manufacturers' instructions. p24 antigen was quantified
by reference to a standard dilution series of the positive
control.
Nested PCR. Viral RNA was extracted from 50- to 200-,I
volumes of plasma and reverse transcribed as previously
described (62). For analysis of proviral sequences, DNA was
extracted from stored PBMCs as previously described (48).
Amplification of proviral DNA or cDNA (except Sc3) was
carried out with primers spanning V3 to V5, a and h (first
polymerase chain reaction [PCR]), followed by a second
PCR using primers b and g (47). For Sc3, a new primer, 633
(sequence GGAGGGGCATACATTGC, 5' base position
7083 in HIVHTLV-IIIB, clone HXB2r [34]), was used in place
of primer h, and primer 634 (ATTCTGCATGGGAGTGTC,
position 7029 in HXB2r) was used in place of primer g.
Nucleotide sequences could in all cases be read from posi-
tions 6614 to 6800 (positions 844 to 1029 in the env region; V3
and flanking regions) and in the V4 and flanking regions from
6938 to 7022 (1165 to 1272 in env). For analysis of sequence
variability, some sequences were slightly longer than this,
extending upstream to position 6581 and downstream to 6848
(V3) and between 6938 and 7115 (V4).
Sequences in the p179a9 region were amplified with prim-
ers of sequences GCGAGAGCGTCAGTATTAAGCGG
(sense outer primer, position 342) and TCTGATAATGCT
GAAAACATGGG (position 865), followed by a second
nested PCR with sense primer GGGAAAAAATTCGGT
TAAGGCC (position 382) and antisense primer CTTCTAC
TACT'T''llACCCATGC (position 817). Nucleotide se-
quences between positions 451 and 793 (p17 coding sequence
plus the 5' 60 bp of p24) were used for sequence comparisons
and evolutionary analysis of the gag region.
Quantitation of provirus in PBMCs was carried out by
limiting dilution as described previously (48). Both negative
and positive controls were included in all PCR amplification
reactions to monitor the sensitivity of the PCR and to detect
possible contamination from product carryover. For nucle-
otide sequence determinations, cDNA or proviral DNA was
amplified at limiting dilution to separate single molecules of
target nucleic acid as previously described (48). Samples
were diluted sufficiently before amplification to ensure that
each nucleotide sequence were derived from one copy of
viral RNA or DNA; frequencies of positive reaction were in
all cases less than 20%. Using standard Poisson formulae, it
can be calculated than greater than 90% of positive reactions
would originate from single molecules of viral nucleic acid
(48). Any sequence showing ambiguities was discarded from
the analysis.
Sequence analysis. Amplified DNA derived ultimately from
single molecules of the HIV genome by limiting dilution was
directly sequenced as previously described (47, 48). Se-
quences were aligned by using PILEUP and LINEUP pro-
grams in the University of Wisconsin Genetics Computer
Group package (11). Sequence variability was expressed as
(i) the number of different nucleotide sequences within a
sample, (ii) the number of polymorphic sites divided by the
number of nucleotides sequenced within a sample (Ps), and
(iii) the mean distance for each pairwise comparison between
nucleotide sequences within a sample (d). Sequence dis-
tances were estimated by using the program DNADIST from
the PHYLIP package (14) under an evolutionary model
assigning different rates of transition and transversion and
different frequencies of the four nucleotides.
Rates of silent substitution per silent site (Ks) and replace-
ment substitution per replacement site (Ka) were estimated
by the method of Nei and Gojobori (35).
Nucleotide sequence accession numbers. All sequences re-
ported in this publication have been submitted to GenBank
(accession numbers L13488 to L13589).
RESULTS
Analysis of HIV sequences upon primary infection. Plasma
samples were collected from three hemophiliacs acutely
infected after transfusion of separate batches of HIV-con-
taminated factor VIII and from three heterosexual contacts
with epidemiologically unrelated primary infections. In five
cases (p74, p84, Scl, Sc2, and Sc3), samples were available
in the interval of transient viremia immediately prior to
seroconversion for anti-HIV antibody. All samples were p24
antigen positive. Anti-HIV-positive, p24 antigen-negative
samples were collected 2 to 12 weeks later from each,
providing evidence for proximity to seroconversion (Table
1). The sixth sample (from p82) was an anti-HIV-positive,
p24 antigen-negative sample collected shortly after serocon-
version. Evidence for proximity to seroconversion in this
case was provided by the finding of an anti-HIV- and p24
antigen-negative sample collected 76 days previously and
restricted reactivity to HIV proteins in an immunoblotting
assay (anti-p24 only; data not shown).
To investigate the extent of sequence diversity in the env
region of initial virus population before seroconversion,
cDNA was synthesized from primers downstream of the V3
and V4 hypervariable regions and titrated to a suitable
limiting dilution to isolate single viral sequences. After
amplification with nested primers, DNA from positive reac-
tions was directly sequenced to prevent in vitro copying
errors by Taq polymerase from influencing our genetic
J. VIROL.
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TABLE 1. p24 and anti-HIV screening of samples collected
during primary infection from five individuals
Route of p24 antigen Time (wk) of firstNo. Anti-HIV I antibody-positivetransmissiona (pg/ml) sample
p74 P Negative 50 4
p84 P Negative 20 6
Scl S Negative 15 12
Sc2 S Negative 500 2
Sc3 S Negative 50 1
p82 P Positive 0 NAb
a P, parenteral; S, sexual contact.
b NA, not applicable.
4 U1
analysis (1, 48). Nucleotide sequence diversity within each
sample was estimated in three ways. First, variation was
expressed as the number of different nucleotide sequences
within a sample. The frequency of polymorphic sites per
nucleotide sequenced (Ps) and the mean pairwise distance
between nucleotide sequences within a sample (d; see Ma-
terials and Methods) were also estimated.
In the env gene, each preseroconversion sample was
homogeneous in sequence in the V4 region (nucleotide
sequences between positions 1165 and 1272 in the env gene
are shown in Fig. 1A) and in V3 (positions 844 and 1029; Fig.
2A), yielding maximum estimates of Pn of as little as
<1/3,276 in the V4 region and <1/9,880 in V3 for the RNA
population in p74 (Table 2). Taking all five of the presero-
conversion samples together, we found no intrasample se-
quence variability in over 44,000 nucleotides sequenced.
This low frequency of substitution contrasts with that found
previously in samples from p82 taken 5 years later, in which
there was extensive variability in both V3 and V4 regions (1,
19, 48). One typical postinfection sample is included in Table
2 for comparison. Several distinct nucleotide sequences
were observed (8 different sequences of 23 obtained in V3
and 12 of 43 obtained in V4), and there was a high frequency
of polymorphic sites (Pn values of 1/186 to 1/127 for V3 and
V4, respectively). Sequence variability was also observed in
the plasma virus population in the V4 (but not V3) region
immediately shortly after seroconversion from p82 (Table 2).
Samples from the six patients with primary infection
yielded distinct V4 region sequences, varying considerably
in both the composition and length of the amino acid
sequence between the conserved flanking regions (Fig. 1). In
common with sequences from long-term-infected individu-
als, all of the six sequences contained frequent (three to six)
potential sites for N-linked glycosylation, none of which
were conserved among all patients. However, in the V3
region, variability was far more restricted, being confined to
nine amino acid polymorphisms in the 35 residues of the V3
loop, compared with 19 in the 27 residues of the flanking
regions shown in Fig. 2. Three potential N-linked glycosy-
lation sites (amino acid positions 295, 301, and 331) are
conserved among all patients, while those at positions 289
and 338 outside the V3 loop are variable between the
sequences analyzed here. Remarkably, two patients with
epidemiologically unrelated infections (p82 [infected in early
1984 from contaminated factor VIII] and Sc3 [heterosexual
contact, 1992]) who had distinct V4 sequences shared ex-
actly the same amino acid (but not nucleotide) sequence in
the V3 loop. Furthermore, these V3 loop sequences were
identical to the global consensus sequence of North Ameri-
can and European isolates (23, 24). Other seroconversion
*4
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p82 RNA AAAACCATAATAGTACAGCTGAAGGAATCTGTAGAAATTAAT TGTACAAGACCCAACAACAATACAAGAAAAAGTATACATATAGGACCAGGA
p74 RNA..T..T........ ...G....G..G
p84 RNA G............. ..... ...G..G
DNA C C .....TCA...G..G
p28 DNA......C .. .......... ...........G.G TCA ...G.
p79 DNA ..... C ............ ...........G G. TCA ...G.
p77 DNA .. G ; ............ ..... ...G..G
Scl RNA ....A. T.TA ........................... C
Sc2 RNA ...GT.C. T.C...A............................G............................... C
Sc3 RNA ....G....T................... . . . . . . . .................................. C
DNA ....G..T...C................. ... ... ... ... ... ............ ... ... ... .. C
937 990 1029
p82 RNA AGAGCATTITATACAACAGGAGAAATAATAGGAGATATAAGACAAGCACATTGT AACCTTAGTAGAGCAAAATGGACTGACACTTTAAGACAG
p74 RNA. .....G. ...A................. A....
p84 RNA ..... G............... .......... G A.A .. A
DNA .A.A.A....
p28 DNA ..... G............... .......... G. A.A. A....
p79 DNA ..... ...............G ....A.......A...
p77 DNA . G......A.A. ......A....
Scl RNA ..... CG. A............... .. ..A. A. .G
Sc2 RNA..... T.. TA.G. A.A. A....
Sc3 NA
....
...
A.A.A. GA. A....
DNA ... A.A.A.GAGA. A...
B 282B 296 306
v v
320 330
v v
343
p82 RNA KTIIVQLKESVZI# CTRPN#NTRKSIRIGPGRAFYTTGEIIGDIRQAHC #LSRAKWTDTLRQ
p74 RNA. . . . V.# .. TS#. M .A. #... T..# . K.
p84 RNA.. # S#R... .S. A...... #E.#N .K.
DNA.. # S# .R. .S..A ......S . E.#N. .K.
p28 DNA.. # S# R. .R.#.9..A ...... . E.N.K.
p79 DNA.. # S#;... R.R. ....A ...... . E.N.K.
p77 DNA.. .# S# .R.P... A #... ... E.#N ..K.
Scl RNA .N. H.#K#... #R .......... .N.... T.#... G.
Sc2 RNA .V.# ......H ... ... G..G ... Y. #I.G...N .K.
Sc3 RNA .S.. N.... ... #I.KT. .EN. .K.
DNA .S.. N...
....
#I.KT. .EN. .K.
Consena ------- ------ CTRPN#NTRKSIH4IGPGRAFYTTGEIIGDIRQAHC ----------
FIG. 2. Comparison of nucleotide (A) and inferred amino acid (B) sequences of viral RNA and proviral DNA in the V3 loop and flanking
regions from individuals with primary HIV infection. The previously published sequence for p82 is included for comparative purposes only.
Sequence numbering and symbols are as described in the legend to Fig. 1. Variable sites and nonconserved glycosylation sites are indicated
in bold.
TABLE 2. Sequence diversity of viral RNA sequences during primary infection and on follow-up
V3 region V4 region
No. Stage of Total no. of No. of different phb Total no. of No. of different psequences sequences (mnmum) sequences sequences n
obtained observed (aiu) obtained observed(mxu)
p74 Pr 40 1 < 1/9,880 21 1 < 1/3,276
p84 Pr 11 1 <1/1,628 11 1 < 1/1,650
Sc1 Pr 26 1 < 1/5,980 26 1 < 1/3,880
Sc2 Pr 29 1 < 1/6,960 11 1 < 1/1,716
Sc3 Pr 24 1 < 1/6,240 24 1 < 1/2,880
p82 Po 12 1 <1/2,880 8 3 1/126
p82 Fo 23 8 1/186 43 12 1/127
a Pr, preserdconversion; Po, Postseroconversion; Fo, follow-up (3 to 5 years).
b P, number of polymorphic sites/number of nucleotides sequenced. When sequences within a sample are uniform, only a maximnum value can be calculated.
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TABLE 3. Sequence diversity of provirus 3 to 6 months after primary infection with HIV-1
V3 region V4 region
No. No. of copies/ Total no. of No. of different Maximum Total no. of No. of different Mamum
sequences sequences pnb sequences sequences p
obtained observed n obtained observed
p28 166 11 1 <1/2,310 11 1 <1/1,969
p77 50 11 1 < 1/2,200 11 1 < 1/1,969
p79 45 9 1 < 1/1,890 9 1 < 1/1,611
p84 60 11 1 <1/1,650 11 1 <1/1,969
Sc3 550 29 1 <1/7,540 29 1 <1/3,480
a Provirus in PBMC DNA quantified by limiting dilution (48).
b See Table 2, footnote b.
sequences are also similar in sequence to the global consen-
sus sequences; those from Scl and Sc2 showed two differ-
ences, while those from p74 and p84 showed three and four,
respectively. In contrast, sequences outside the V3 loop
differed considerably between the seroconversion samples.
Indeed, sequences of p82 and Sc3 that were identical in the
V3 loop differed from each other at 8 of the 27 flanking region
sites. Possible reasons for the similarity of amino acid
sequences in the V3 loop but not in flanking regions are
discussed below.
Persistence of preseroconversion sequences in PMBCs. We
have previously found that seroconversion-type sequences
can persist as a (minority) component of proviral sequences
in PBMCs several years after primary infection (49). To
investigate this phenomenon of persistence in more detail,
we obtained samples collected after seroconversion from
p84 (estimated interval from seroconversion, 15 weeks) and
Sc3 (6 weeks). Neither sample contained any circulating
RNA sequences detectable by PCR, but both contained high
frequencies of provirus-bearing PBMCs (60 to 550 copies of
provirus per 106 cells; Table 3), comparable to those of
long-term-infected asymptomatic individuals (48). Proviral
sequences from both samples were completely homoge-
neous in V3 and V4 regions of env (combined maximum P,
values of <1/11,380 and <1/3,619 for Sc3 and p84, respec-
tively). Furthermore, in both cases, proviral nucleotide
sequences were identical to those of the corresponding
preseroconversion plasma RNA samples (Fig. 1 and 2),
indicating that the two populations are for practical purposes
equivalent. Similarly, the proviral sequences of postserocon-
version samples from three more hemophiliacs (p28, p77,
and p79) were homogeneous in the V3 and V4 regions (Table
3). Taking these five samples together, no intrasample se-
quence diversity was observed in the 26,588 proviral nucle-
otides analyzed, providing substantial evidence that what-
ever diversification may be taking place in the plasma or
elsewhere in the infected individual, such changes are not
represented in the PBMC population for many months (see
Discussion).
Evidence for selection of specific env sequences before
seroconversion. The complete homogeneity in sequences in
the env region could be explained in two different ways.
First, it is possible that the initial virus population consisted
of the progeny from a single infecting virus particle and that
too few rounds of replication occurred between exposure
and seroconversion for sequence diversity to develop. Al-
ternatively, the lack of diversity in the env region could have
resulted from selection for specific sequence variants before
seroconversion which outcompeted other cotransmitted
variants (see Discussion). We have carried out two investi-
gations to distinguish between the two possibilities.
If the homogeneity of env sequences was the result of
selection, then we might be able to observe variability in
other regions of the genome not subject to the same selective
pressures. To investigate this possibility, sequence analysis
of part of p179a9 gene was carried out on the preseroconver-
sion RNA samples and postseroconversion DNA samples
(Fig. 3), and the diversity was compared with that of the env
sequences (Table 4). In contrast to V3 and V4, we found
frequent nucleotide substitutions in seven of nine samples
analyzed. Variability was found in both preseroconversion
RNA and postseroconversion DNA samples and in cases of
both sexual and parenteral transmission of HIV. Compari-
son of the combined results allows us to discount sampling
as a possible explanation for the differences between the
two regions. In the env region, a total of 190 sequences in the
V3 and V4 regions combined yielded no intrasample varia-
tion (P, < 1/67,900), while analysis of 103 p17 sequences
yielded 21 variant sequences and a frequency of intrasample
variable sites of approximately 1/430. Indeed the range of
variability in the gag region for the patients with primary
infection (P,,n = 1/305 to 1/1,542) overlaps that of long-term-
infected individuals (1/205 to 1/405; Table 4).
Taking all of the pl7gag sequences together, only 34 of the
71 observed nucleotide differences led to an amino acid
change, lower than that expected for randomly mutating
DNA. Even lower proportions of nonsynonymous nucle-
otide changes are observed within individual populations; of
43 intrasample variable sites, only 15 led to amino acid
substitutions. The ratio of synonymous (Ks) to nonsynony-
mous (Ka) substitutions in the preseroconversion samples
was 3.2, similar to that found between isolates (25) and in
two long-term-infected patients (ratios of 6.1 and 2.7 for s44
and p82, respectively). The frequency of G + A transitions
in the region analyzed was 52% (37 of 71).
The second piece of evidence for specific selection of
particular env sequences is provided by a comparison of V3
and V4 sequences at seroconversion of four hemophiliacs
exposed to the same infectious source, a batch of HIV-
contaminated factor VIII (27). In the absence of selection,
seroconversion sequences in recipients should be a random
selection of env variants present in factor VIII. However,
comparison of the V3 and V4 sequences from p28, p77, p79,
and p84 reveals far greater sequence similarity than would be
expected from nonselective transmission (Table 5). All four
hemophiliacs show identical sequences in V4 and flanking
regions (Fig. 1), while three of the four hemophiliacs are
identical in the V3 region (Fig. 2). The fourth, p79, shows a
single nucleotide substitution in the V3 loop, leading to the
replacement of proline for serine at position 308. This degree
of variability in the env region is far lower than has ever been
observed in viral RNA sequences of seropositive individuals
VOL. 67, 1993
Sc3-a ... A.TA.A A..... ..A.TG.T..... GT. AG.A.GC ..C...... 5
-f ... A.TA.A...A.TA.GAA .. TA.TG.T...... T AG.A.GC...... G . 1
J
... A.TA.A..... A.A..GAA ...TA.TG.T
.....
A T AG.A.GC ..C.A GAA . 1
GGGGAGGCGGAGCCGGGCATCCACGATGGGGAACGTCGGGCAGAAGGCAGCCATAGTAGCACGGTGT
loos 4 5 6 7
lOs 6 7 8 0 1 2 3 4 6 0 1 5 6 7 8 9 0 1 3 4 6
ls 38191994703272949277352570717
HXB2r R A V E G G Q S L Q T R R E K E K KA D G H N Q V Y I M H
p74-a,b . . . . . . . A . . . . . . R . . . A .NS. .L. . 13
-c
. . . . . . A . . A . . . R . . . . A ..S . . . L .. 1
R -d . . . . . . A . . . . . . R . . . . A ..S . . . L . 1
N Scl-a . . L . . E . . . K . . K N G NS . . . L 19
A Sc2-a . . . . . E .A . . . . K . . . . . . G .N S P . . L .. 18
Sc3-a,d e Q S . . . E .A I K ..K . . . . . E G .N S .A .M .. 10
-b Q S . . . E .A I K .K . . . E . E G .NS.A.M. . 1
-c Q S . . . E .A I K .K . . . . E E G .NS.A.M. . 1
p84-a . . . . . . . A . . . .KT. . NS S. L . . 3
-b . . . . . . . A . . . . . . . . . . . . . N S .G .L .Q 1
-c . . . . . . . A . . . . K . . . . . T ..N S .S .L.Q 1
-d . . . . S R . A . . . . K . .K . T. . N S S .L I. 1
-e . . . . . . . A . . . . K . . . . . T ..N S .S S L .. 1
D -f . . . . . . . A . . . . . . . . . . . . . . S G .L.. 1
N p28-a . . . . . . . A . . . . K . . . . . T . N S .S .L.. 8
-b . . . . . . . A . . . . K . . . . . T .E N S .S .L. . 1
A
p79-a . . . . . . . A . . . . K . . . . . T ..N S .S .L.. 5
-b . . . . . . R A . . . . K . . . . . T ..N S .S .L.. 1
p77-a . . . K . . . A . . . K K . . . . . T . .NS .S.L. . 4
-b->-f A .. . . K . . . . . T . .NS .S.L. . 5
Sc3-a,f Q S . . . E .A I K ..K . . . . . E G .N S .A .M .. 6
-g Q S . . . E .A I K K . . . E G .N S .A .M I. 1
|HXB2r A V E G G Q S L Q T R R E K E K K A D G H N Q V Y I M H
lOOs 1 2
lOs 5 6 7 8 0 1 2 3 4 5
ls 4 6 7 3 7 3 6 8 9 0 1 7 2 4 6 8 3 4 9 2 4 5 7 8 9 3 9 3 5
R
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A 100s 4 5 6 7
lOs 5 6 78 90 1 2 3 4 567 901 2 34 5 6 7 8 90 1 34 56 78
ls 1253481259113689059470392159724596951404291273787357235780067921702
IHXB2 GGGGAGGCGGAGCCGGGCATCCACGATGGGGAACGTCGGGCAGAAGGCAGCCATAGTAGCACGGTGT
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n
p74-a ... T.G... ... .. .G. .G. .. ...G ... C.A.GC...... CT. 12
-b .C.. T.G ...G . T.CC.A.G.C... ... .C.A.GC. CT. 1
-c. T.G. G. ... C.G. G.C.0. ... ....1...C. 1
R -d. T.G. G. C. G..C. G...C...GC.C... 1
N Scl-a ...... C.A. A.A .... .A.. T.A...... GA.G.A.GC. CT. 19
A Sc2-a. TA... T..A..G. T..A. .... G..T.A.G.GG.A.GCC. C...... 18
Sc3-a ... A.TA.A. A...... .T..A.TG.T. .... .T AG.A.GC. ..... ... 8
-b ... A.TA.A. A...... .T..A.TG.T.G... .TG. AG.A.GC. ..... ... 1
-c .. A.TA.A. A.......T. .A.TG.T. .... T. .G.AG.A.GC. .C... .... 1
-d .. A.TA.A. ....A .GAA .TA.TG.T .....T.AG.A.GC.C.G... G.... C 1
-e .A.TA.A... T... A..G... T. .GA.TG.T .....T.AG.A.GC. ...... .. 1
p84-a ..A.. T.G.T.G T T.A............... C 3
-b. T.G. G TG G .... A.GC. .... .0.. ..A 1
-c .A.. T.G.GT.AG A ..A...A.G....G ....A ...C .A 1
-d A.A... T.GA..AA... .. T.G.A....A GC.AA ......... C.. A.A. 1
-e .A.. T.G. G T T.A ... .A.GC.AGC. ...... 1
D -f .AA.T.G.T.. .....0.1
p28-a .A.... T.G....... TG.A.. ..A..... .....A... .. 8
N -b .A.... T.G.....TA G A.G.A ..AA.GC.AG.... C...... 1
p79-a .A.... T.G....T..G T TG.A....... .....A... .. 5
A -b .A.... T.G....GG .A.. T..A..... ...... ... .. 1
p77-a .A.... T.G.A.... T.G T G.A.A....AG............ .. 4
-b .A.. TAG.A...G .AT.AA..... G ....... A.GC.AG ..C 1
-c .A.. T.G.A GT....TG.A.... A G...... ... C.. 1
-d .A.G... T.G.A.GT....TG.A .GC.AG.... ... 1
-e .A.. T.G.A G T....T..A.. A G....... ... C.. 1
-f .A.A...T .G.A . T.G. T.A.A. .G .....G ........ C.. 1
=
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TABLE 4. Comparison of env and gag sequence diversity during primary infection
V3/V4 region plWag region
No. Sample' Stageb Total no. of No. of different pnc Total no. of No. of different P(
sequences sequences (maximum) (%)d sequences sequences (maximum) d
obtained observed obtained observed
p74 RNA Pr 40 1 < 1/13,156 0.0 15 4 1/1,029 0.3
Scl RNA Pr 26 1 < 1/9,860 0.0 19 1 < 1/6,517 0.0
Sc2 RNA Pr 29 1 < 1/8,676 0.0 18 1 < 1/6,174 0.0
Sc3 RNA Pr 24 1 < 1/9,120 0.0 12 5 1/1,029 0.2
p28 DNA Po 11 1 < 1/4,279 0.0 9 2 1/1,542 0.1
p77 DNA Po 11 1 < 1/4,169 0.0 9 6 1/343 0.6
p79 DNA Po 9 1 < 1/3,501 0.0 6 2 1/1,029 0.1
p84 DNA Po 11 1 < 1/3,619 0.0 8 6 1/305 0.9
Sc3 DNA Po 29 1 < 1/11,020 0.0 7 3 1/400 0.5
p82 RNA Fo 43 18 1/160 2.5 14 14 1/205 1.7
s44 RNA Fo 13 10 1/405 1.0
a RNA, viral RNA sequences in plasma preseroconversion; DNA, proviral sequences from PBMCs postseroconversion.
b See Table 2, footnote a.
c See Table 2, footnote b.
d d (%), mean percentage nucleotide distance between sequences within a sample.
and many orders of magnitude lower than that of the
follow-up sample from p82 (Table 2). It is therefore likely
that only the subset of virus variants within factor VIII
bearing the observed V3 and V4 sequences at seroconver-
sion were capable of virus transmission. In contrast to the
envelope region, high degrees of sequence variability were
observed in gag; inter- and intrapatient variability was
comparable to that of long-term-infected individuals, consis-
tent with our observations of other patients in this study.
DISCUSSION
Homogeneous env sequences at seroconversion. In this
study, we have carried out extensive sequence analysis of
two normally hypervariable regions of the env gene (V3 and
V4) to characterize the initial virus population associated
with primary infection by HIV. A striking feature of the data
obtained was the absence of any sequence heterogeneity in
these regions in any of the nine acutely infected individuals.
Among viral RNA sequences obtained before the first ap-
pearance of anti-HIV antibody, we found no variability in a
total of 44,090 nucleotides sequenced, while among the
postseroconversion proviral DNA sequences, none was ob-
served in 26,588 nucleotides.
The detection of such low rates of sequence variability
within the initial virus populations was made possible by the
use of a method for sequencing PCR-amplified DNA (47, 48)
that avoids the problems of copying errors by Taq poly-
merase, in vitro recombination, and selective amplification
that other methods inevitably encounter (32, 33). In contrast
to our results, other studies have found far greater sequence
heterogeneity of viral populations around the time of pri-
mary infection (37, 60). In the former study, substitutions,
frameshifts, and stop codons were found scattered through-
out V4 but also in the normally well conserved C4 region in
proviral sequences taken within weeks of seroconversion. In
the latter, some of the postseroconversion sequences ob-
tained from amplification of plasma virus showed substitu-
tions in the normally invariant cysteine residues spanning
the V3 loop. In both studies, nucleotide sequences were
obtained by cloning PCR products and are therefore subject
to potentially high rates of in vitro copying artifacts. The
frequency of copying errors associated with this method
ranges from as high as 1/350 in one study (12) to 1/1,800 (13).
These rates are considerably higher than the heterogeneity in
the in vivo virus populations that we found in the env gene.
As neither of the two previous studies of primary infection
by HIV carried out control experiments to determine the
error rate associated with cloning, we cannot rule out the
possibility that some or all of the sequence variability
observed in proviral sequences shortly after seroconversion
(37) and a proportion of the amino acid substitutions in the
V3 region (60) originated from in vitro copying artifacts
rather than representing genuine viral sequence heterogene-
ity.
Evidence for selection in primary infection. A monotypic
population of env sequences on primary infection could arise
in three ways. First, each primary infection with HIV may
be the result of infection from a single viable virus particle.
The uniformity of the env sequences would then simply
reflect the fact that there were insufficient numbers of
replicative cycles to allow measurable diversification of the
initial virus population. Alternatively, in the case of trans-
mission and coinfection with several different viruses, one
virus might outgrow the others by chance and lead to the
observed uniform population. In neither of these models is it
necessary to invoke specific selection to explain the ob-
served reduction or absence of sequence variability of env
sequences found in this or previous studies of sexual trans-
mission (60). Similarly, the observed reduction of sequence
variability of the env gene found upon mother-to-child trans-
FIG. 3. Comparison of variable sites of nucleotide (A) and inferred amino acid (B) sequences within part of the p179e9 gene (343 bp) from
individuals with primary HIV infection with the sequence of pHXB2r. Nucleotide positions (numbered from the start of the pHXB2r
sequence) of polymorphic sites are shown at top of each panel; variable amino residues are indicated at the bottom of panel B. The number
of observed occurrences of each sequence variant (n) is recorded at right of each panel.
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TABLE 5. Combined diversity of env and gag sequences in four
individuals exposed to the same source of infection
Total no. of No. of different p b
Region sequences sequences ,n d(%u)C
obtained' observed (maximum)
V3 42 2 1/4,025 0.02
V4 42 1 <1/7,518 0.00
pl7gag 32 14 1/499 0.60
aCombined analysis of sequences from four hemophiliacs (p28, p77, p79,
and p84) exposed to the same source of HIV infection analyzed together.
b See Table 2, footnote b.
c See Table 4, footnote d.
mission (61) clearly does not in itself provide any evidence
for selective transmission of particular variants of HIV.
However, neither of these simple explanations can explain
why there should be at least 100-fold-greater sequence
diversity in the gag region in the samples from seven of the
nine individuals with primary infection. There is no a priori
reason to suppose that the mutation rate of the gag region
should be so much higher than that of the env region,
particularly when sequence variability in the gag region is
generally much less than that in the env region in long-term-
infected individuals. Furthermore, the observation that two
patients showed no variability in p17&a& (combined P1,, of
<1/12,691) also shows that any such diversification process
in gag does not necessarily always occur.
Sequence change to prevent binding to major histocom-
patibility complex class I molecules has been reported to
occur in the p17 region of gag (38), and it possible in
principle that the heterogeneity of gag sequences observed
at seroconversion was the result of positive selection to
evade immunological recognition. However, the majority of
sequence changes in the gag region were silent, in that they
did not affect the encoded amino acid sequence (Fig. 3), and
therefore could have no conceivable effect on class I or
T-cell receptor binding or on viral phenotype. As we cannot
account for the diversity of gag sequences in terms of the
simple models described above, we infer that the contrasting
homogeneity of env sequences is the result of strong selec-
tion before seroconversion, and we propose that only a small
proportion of env sequence variants are capable of causing
primary infection.
From the data that we have presented, it is not possible to
conclude where the process of population expansion and
generation of sequence diversity in the gag region occurs.
One possibility is that transmission of a single virus particle
was responsible for primary infection and that extremely
rapid diversification leads to the observed variability in the
gag region upon primary infection, while selection for a
specific determinant close to V3 or V4 eliminates detectable
sequence heterogeneity in this region in the initial virus
population.
An alternative possibility is that the exposed individual is
nonselectively infected with several viruses bearing a range
of gag and env sequences. Specific selection for viruses
bearing the putative env determinant then takes place in the
contact in the interval between exposure and seroconver-
sion. The observed variability ofgag sequences upon acute
primary infection arises by recombination between env and
gag sequences. Such recombination could take place within
the acutely infected individual between exposure and sero-
conversion; alternatively, recombination may have already
occurred in the individual who was the source of infection,
and there was cotransmission of a series of hybrid viruses to
the contact. In this model, it is likely that the predominant
sequence in the gag region is the one originally associated
with the selected env sequences, while the single occur-
rences of the alternative gag variants represent those of
viruses generated by recombination. The frequency with
which this process is observable varies considerably be-
tween individuals; in p84 and p77, 5 of 8 and 5 of 9 viral
sequences may be such recombinants, while none were
observed in 18 to 19gag sequences from Scl or Sc2, perhaps
because of less frequent recombination. However, it is also
possible that the homogeneous gag sequences in Scl and
Sc2 at seroconversion arose from greater sequence similarity
in the transmitted variants or from the transmission of
relatively few or even a single virus particle.
Although we cannot distinguish between these or other
possible series of preseroconversion events, they all imply
strong selection for specific determinants close to V3 or V4
upon primary infection. This conclusion is supported by our
observation that recipients of the same batch of factor VIII
seroconverted with identical V4 and almost identical V3
sequences following exposure to what was probably a het-
erogeneous mixture of env sequence variants such as is
found in plasma of long-term-infected individuals (Table 4).
Localization of the determinant selected upon transmission.
In this study, we observed no sequence variability in either
the V3 or V4 region of env. However, this observation does
not in itself localize the actual determinant of selection, as
strong selection tends to eliminate variation at linked neutral
sites. Thus, we cannot conclude from these data alone that
there is selection for specific V3 or V4 sequences; all we can
say is that the determinant that is selected is much closer to
V3 and V4 than it is to p179a9, as the frequency of recom-
bination between two sites is likely to be proportional to
their physical separation in the viral genome.
Comparison of primary amino acid sequences reveals no
similarity in the V4 or flanking regions between the patients
with epidemiologically unrelated infections that would local-
ize such a determinant to this region of the env gene. Indeed,
the V4 sequences are so different from each other that
simply attempting an alignment of the sequences is difficult
to justify (Fig. 1). Apart from the homogeneity within each
sample, they differ little in composition from those found in
long-term-infected individuals; potential N-linked glycosyla-
tion sites are frequently found in all six patients, as is
sequence duplication and deletion (47).
On the other hand, variability in the V3 region appears to
be restricted in the initial virus population of different
patients. Despite being epidemiologically unrelated, the
amino acid, but not the nucleotide, sequences of the V3
loops from variants infecting p82 and Sc3 were identical.
Variability was also highly restricted among viruses charac-
terized from the other four epidemiologically unrelated
transmissions, differing from each other by a maximum of 6
from 35 amino acid residues. It is also significant that the two
identical sequences from p82 and Sc3 were identical to the
global consensus sequence of North American and Euro-
pean sequences (23, 24), providing some evidence that virus
variants in most infected individuals derive from this specific
sequence. The restriction in sequence variability observed in
the V3 loop does not extend to the flanking regions of V3.
Most revealingly, the sequences in the flanking regions of
variants from p82 and Sc3 differ substantially from each
other, hinting at a very sharp boundary between the region
that is subject to the putative selection process and regions
J. VIROL.
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outside the loop where amino acid substitutions appear not
to be constrained.
The outcome of the selection process is that the initial
virus population is essentially clonal in origin in the selected
region (env) but polyclonal and hence variable elsewhere.
The apparent requirement for a specific env determinant
upon primary infection may account for the stochastic
nature of virus transmission. For example, only 18 of the 32
recipients of an HIV-contaminated batch of factor VIII
actually became infected (27), and the risk of infection
correlated with the number of bottles transfused, implying
that fully infectious virions were relatively rare in the factor
VIII. This is despite the fact that each of the 32 hemophiliacs
receiving the batch was probably exposed to viable virus if
the model of multiple transmission outlined above is correct.
The absence of infection in half of the cohort can thus be
explained on the basis that none of the transmitted variants
in these patients had env sequences to permit seroconver-
sion. The fate of transmitted viruses in such cases of
nonproductive infection is unclear. However, it should be
noted that transient T-cell proliferative responses have been
detected several months before seroconversion in individu-
als exposed to HIV (7), suggesting substantial virus replica-
tion before the onset of primary infection. Furthermore,
evidence for cell-mediated immunity has been found in
individuals who are at risk for infection by HIV from
unprotected sexual intercourse but who remain seronegative
(8). In such individuals, it is possible that there is indeed
transmission and limited viral replication of HIV, but that
the infection does not necessarily progress to systemic
spread and seroconversion.
Phenotype of the selected env sequences. It is now reason-
ably clear that there are differences in cytopathology and cell
tropism between isolates obtained during the early asymp-
tomatic stage of infection and those from patients with AIDS
or AIDS-related complex (3, 15, 51). Isolates from early
stages of infection generally grow more slowly, do not
induce syncytia between infected cells, and retain a capabil-
ity to replicate in primary macrophages as well as in acti-
vated CD4' lymphocytes. Later in infection, variants that
are highly cytopathic upon virus culture (SI) and have lost
their ability to grow in macrophages may appear (45).
Consistent with this time course, it has been found that HIV
isolates collected at the time of primary infection are gener-
ally NSI and macrophage tropic (6, 9, 40). However, in one
of the studies (40), 3 of the 19 virus isolates collected before
seroconversion were SI and non-macrophage tropic. The
detection of this more virulent phenotype at seroconversion
correlated with a subsequent more rapid progression to
AIDS than observed in those infected with NSI variants (40).
The status of the V3 loop as a determinant of biological
phenotype is uncertain. For certain virus isolates, in vitro
recombination experiments have implicated regions includ-
ing V3 as necessary and sufficient determinants of macro-
phage tropism and cytopathology (4, 5; 15, 16, 20, 36, 46, 50,
55, 56). Comparison of V3 sequences of SI and NSI virus
isolates indicated a significant association between the pres-
ence of acidic amino acid residues at position 306 and/or 320
and the SI phenotype (16); these predictions have since been
experimentally verified by site-directed mutagenesis of an
HXB2-like isolate (10). Although the properties of the deter-
minant in env selected upon virus transmission cannot be
established with any certainty, it could be predicted that
virus isolates from p82, p84, p74, Sc2, and Sc3 should be
NSI, while Scl should be SI.
In another study, V3 sequences of noncytopathic and
macrophage-tropic variants showed substantially restricted
sequence variability compared with the sequences of T-cell-
tropic variants and were also similar or identical to the global
consensus of 245 North American virus isolates (5). There is
a striking similarity between the overall sequences of pre-
seroconversion sequences reported in this study with mac-
rophage-tropic variants, in terms of both the positions where
substitutions occurred and the actual amino acid residues
substituted. For example, substitution of lysine by arginine
and of threonine by alanine occurred at positions 305 and
317, respectively, in two patients in our data set and fre-
quently among macrophage-tropic variants (5, 16).
We and others have described the slow diversification of
PBMC sequences over several years of infection (30, 49). In
both studies, variants found early in infection had V3 se-
quences similar to the macrophage-tropic/global consensus,
but these were replaced by a range of sequence variants with
predicted SI phenotypes (16). These observation support the
hypothesis that the determinant associated with primary
infection is indeed macrophage tropism or an associated
property, although it is intriguing that this appears to be the
case irrespective of whether infection was acquired by
sexual contact or parenterally.
V'irological events during primary infection and seroconver-
sion. We have previously found that V3, V4, and V5 se-
quences found at seroconversion may persist unchanged as a
increasingly small component of the proviral population over
the years following primary infection (49). In contrast, such
sequences disappear completely from the plasma virus pop-
ulation immediately after seroconversion. From other stud-
ies, it has been found that plasma RNA sequences in early
stages of infection (60) are orders of magnitude more heter-
ogeneous than RNA sequences analyzed preseroconversion
and the population of proviral DNA sequences found in
PBMCs several months after seroconversion in this study.
The persistence of sequences in PBMCs identical to those
of plasma virus preseroconversion is therefore not necessar-
ily associated with their continued active expression. In-
deed, we found that the frequencies of provirus-bearing cells
shortly after seroconversion were typical of those of asymp-
tomatic, HIV-seropositive individuals in the clinically silent
stage of HIV infection (39, 49), even though plasma virus
had fallen to low or undetectable levels. Furthermore, the
V3 and V4 sequences of the DNA samples taken shortly
after infection from p84 and Sc3 were homogeneous and
identical to those found in each corresponding preserocon-
version RNA sample (Fig. 1 and 2), while gag sequences
showed equivalent degrees of variability (Table 4).
It is possible that the provirus-bearing cells detected after
seroconversion represent cells nonproductively infected
during primary infection, either through integration of pro-
virus at a site in a chromosome unfavorable for RNA
transcription or from infection with a mutated virus incapa-
ble of cytopathic virus replication. Although we did not
identify the cell type bearing provirus in the immediate
postseroconversion period, it is significant that the most
frequently infected cell type in both HIV and simian immu-
nodeficiency virus infection is the CD45RO+ memory cell
(43, 57). Indeed, it is possible that those naive CD4+ T cells
that become activated are the main targets HIV during the
period of acute viremia that precedes seroconversion. The
overwhelming majority of such cells would probably have
been destroyed at this stage, as shown by the transient drop
in total CD4+ counts and the extremely high numbers of
HIV-infected cells during primary infection (9, 22). How-
ever, those that do survive proceed to differentiate into
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memory cells, each bearing a single copy of an inactive
integrated provirus and an unaltered phenotype. These cells
or their descendants would continue to circulate within the
seropositive individual for several years. Therefore, in the
very early stages ofHIV infection, the only DNA sequences
obtainable by PCR are simply copies of the initial virus
population. The fact that such viruses are those that failed to
productively infect the host cell may explain the well-known
difficulty in isolating HIV from some individuals early in
infection, even when substantial numbers of PBMCs contain
proviral DNA (2, 42, 53).
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